Merit Medical Systems (NASDAQ:MMSI) announced its earnings results on Wednesday, April 25th. The medical instruments supplier reported $0.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.02, Bloomberg Earnings reports. Merit Medical Systems had a net margin of 2.37% and a return on equity of 10.01%. The firm had revenue of $203.04 million for the quarter, compared to analysts’ expectations of $192.60 million. During the same period in the prior year, the company earned $0.28 EPS. The business’s revenue was up 18.7% compared to the same quarter last year.
Shares of NASDAQ:MMSI opened at $52.70 on Friday. Merit Medical Systems has a 52 week low of $50.55 and a 52 week high of $51.45. The company has a current ratio of 2.76, a quick ratio of 1.42 and a debt-to-equity ratio of 0.53. The company has a market capitalization of $2.62 billion, a price-to-earnings ratio of 39.39, a PEG ratio of 2.45 and a beta of 1.33.
Several equities research analysts have weighed in on MMSI shares. Zacks Investment Research downgraded shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a research note on Wednesday, May 2nd. BidaskClub upgraded shares of Merit Medical Systems from a “hold” rating to a “buy” rating in a research note on Tuesday, May 1st. Needham & Company LLC raised their target price on shares of Merit Medical Systems from $53.00 to $54.00 and gave the stock a “buy” rating in a report on Thursday, April 26th. Raymond James raised their target price on shares of Merit Medical Systems from $50.00 to $51.00 and gave the stock an “outperform” rating in a report on Thursday, April 26th. Finally, ValuEngine raised shares of Merit Medical Systems from a “hold” rating to a “buy” rating in a report on Monday, April 2nd. One equities research analyst has rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $49.83.
About Merit Medical Systems
Merit Medical Systems, Inc designs, develops, manufactures, and markets various disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides various peripheral intervention products, including access, angiography, intervention, and drainage and biopsy products to alleviate patients suffering from peripheral vascular and non-vascular diseases; and cardiac intervention products to aid in the treatment of various cardiac conditions specific to interventional cardiology and electrophysiology, including cardiac rhythm management and lead management.
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.